Menu Back toAdvanced Clinical Innovation Theater: Decentralized Clinical Trials: The Wave of the Future
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
Advanced Clinical Innovation Theater: Decentralized Clinical Trials: The Wave of the Future
- United States
The impact of COVID-19 on clinical trials has been substantial. For example, travel bans and site closures have forced a rapid shift in the running of physical clinical investigative sites toward purely virtual environments. While the concept of virtual clinical trials has been around for a number of years, the decision to actually run a trial has remained somewhat optional. Now, sponsors are now finding themselves forced into either fully virtualized trials and/or hybrid trials, out of necessity. However, there are silver linings – especially when it comes to the potential for adapting quickly to unforeseen situations like remaining efficient and profitable amidst a pandemic. We will explore how the required adoption of virtual recruiting, telemedicine, remote monitoring and at-home healthcare visits have taught us valuable lessons about how to run more agile and adaptive trials; and how these learnings will shape the future of R&D.
Learning Objective : Describe how COVID-19 has impacted trial operations across the globe; Discuss how trial sites have adapted through the use of virtual trial elements; Identify the challenges both sponsors and CROs have faced in this process - and how to overcome them.
- Senior Vice Presiident, European Operations
- Advanced Clinical, United Kingdom
Domantas Gurevicius, MHS
- Sr. Director, Clinical Monitoring
- Advanced Clinical, United States